Sun Pharmaceutical Industries Limited completed the private placement allotment of Rs 7,816 crore in rated, listed, unsecured, redeemable, non-convertible debentures (NCDs) on October 26, 2026, exceeding the base issue size of Rs 7,000 crore by exercising a greenshoe option of Rs 816 crore. The NCDs consist of Series A debentures with an aggregate face value of Rs 2,003 crore and Series B debentures with an aggregate face value of Rs 5,813 crore, and will be listed on the National Stock Exchange of India Limited and BSE Limited, with a scheduled redemption date of October 27, 2031.